发明名称 |
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
摘要 |
Use of a compound having 50% activity or more of the activity of gastric inhibitory polypeptide, GIP, when tested in the same assay under the same conditions, and/or the use of GIP, analogues and fragments thereof, for the manufacture of a pharmaceutical composition for prophylaxis and/or treatment of conditions caused or characterized by abnormal loss of cells and/or for prophylaxis and/or treatment of over weight and obesity. A compound as described above for the prophylaxis and/or treatment of over weight and obesity. Use of antagonists to GIP or the GIP receptor for the prophylaxis and/or treatment of disorders caused or characterized by hyperproliferation of cells and/or abnormally low body weight.
|
申请公布号 |
US2005245441(A1) |
申请公布日期 |
2005.11.03 |
申请号 |
US20050518159 |
申请日期 |
2005.01.18 |
申请人 |
NYBERG JENNY;ERIKSSON PETER |
发明人 |
NYBERG JENNY;ERIKSSON PETER |
分类号 |
A61K38/00;A61K38/17;A61K38/22;A61P3/04;C07K14/575;(IPC1-7):A61K38/17 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|